Abstract:Part 1 Isolation and cultivation of influenza virus on mammalian cells: an overview of host cell selection, J.S. Robertson suitability of MDCK cells grown in a serum-free medium for influenza virus production, N. Kessler et al production of influenza virus in serum-free mammalian cell cultures, O.W. Merten et al growth and immuno-genicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs, E.A. Govorkova evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model, K. Nerome et al cell culture for surveillance of influenza, M. Zambon. Part 2 Selection of vaccine strains: generation and characteristics of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells, J.M.T. Voeten et al. Part 3 Scale up for vaccine production: influvac tl- a safe Madin Darby canine kidney (MDCK cell culture based influenza vaccine, R. Brands et al development of a vero cell-derived influenza whole virus vaccine, O. Kistner et al. Part 4 Clinical trials: safety, reactogenicity and immunogenicity of Madin Darby canine kidney cell-derived inactivated influenza subunit vaccine - a meta-analysis of clinical studies, A.M. Palache et al A phase I, randomised controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line, P.B. Percheson et al. Part 5 General regulatory issues I - cell substrates: experience with vero cell at Pasteur Merieux Connaught, B.J. Montagnon et al quality assurance for cell substrates, G.N. Stacey, P. Phillips WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals - application to influenza vaccine production, E. Griffiths ICH guidelines and PhEur monographs on derivation and characterization of cell substrates used for production of biotechnological/biological products, R. Dobbelaerg. Part 6 General regulatory issues II - cell culture influenza vaccines: regulatory perspective in the United States on cell cultures for production of inactivated influenza virus vaccines, R.A. Levandowski cell culture influenza vaccine - an Australian perspective, L. Chang et al the influence of the host cell on standardization the neuraminidase content of influenza vaccines, L. Gerentes et al.

Synthetic Cell Lines for Inducible Packaging of Influenza A Virus

High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines

High-throughput investigation of genetic design constraints in domesticated Influenza A Virus for transient gene delivery

Generation of a Live Attenuated Influenza A Vaccine Using Chemical-Triggered Intein.

Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics

Transcriptomic Characterization Reveals Attributes of High Influenza Virus Productivity in MDCK Cells.

Replication-competent influenza virus with a protein-responsive multiplication ability

In vitro one-pot construction of influenza viral genomes for virus particle synthesis based on reverse genetics system

Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system

Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells

Production of influenza virus-like particles using recombinant insect cells

Process development for pandemic influenza VLP vaccine production using a baculovirus expression system

A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.

Generation of a high yield vaccine backbone for influenza B virus in embryonated chicken eggs

Reverse genetics plasmid for cloning unstable influenza A virus gene segments.

Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations

Generation of a pdmH1N1 2018 Influenza A Reporter Virus Carrying a mCherry Fluorescent Protein in the PA Segment

Inactivated influenza vaccines prepared in cell culture : National Institute for Biological Standards and Control, Potters Bar, Herts., U.K. September 26-27, 1997

Locations and structures of influenza A virus packaging-associated signals and other functional elements via an in silico pipeline for predicting constrained features in RNA viruses

Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs